Table 5.

Classification of clinical scales used in urological disorders and applied to PD patients

Urinary scales applied to PD	Use in PD	Use beyond original developers	Successful clinimetric testing	Clinical limits/advantages	Classification
IPSS	X	X μ	X in non‐PD. Very limited clinimetric data in PD. Not enough sensitive to change in PD	Brief ‐ one Qol item. Excludes incontinence	Suggested
Dan‐PSS	X	X μ	X in non‐PD. One limited study with clinimetric data in PD. Considered as a valuable tool	Includes incontinence and QoL. More sensitive than the IPSS	Recommended with caveats. Further validation in PD required
ICIQ‐MLUTS (ICS male SF)	X	X μ	X in non PD. No clinimetric data in PD.	Applicable to males and females. Assesses all LUTS	Recommended with caveats. Further validation in PD required
OAB q	X	X μ	X in non PD. No clinimetric data in PD.	Applicable to males and females. Focused on OAB	Recommended with caveats. Further validation in PD required
OAB q SF (ICIQ – OABqol)	X	X μ	X in non PD. No clinimetric data in PD.	Applicable to males and females. Focused on OAB	Recommended with caveats. Further validation in PD required
OAB‐V8	X	X μ	X in non PD. No clinimetric data in PD.	Applicable to males and females. Focused on OAB Screening tool	Recommended with caveats. Further validation in PD required Screening tool
OABSS	X	Xμ	X in non PD. No clinimetric data in PD.	Applicable to males and females. Focused on OAB	Recommended with caveats. Further validation in PD required
UDI (short form)	Only one study in PD. No clear results in PD	X μ	X in non PD. No clinimetric data in PD.	Use mainly in women.	Listed. Additional studies in PD needed

μ: Use beyond developers mainly in non PD patients.

All these scales have been designed to assess the severity of urinary symptoms.